Cite
HARVARD Citation
Strati, P. et al. (n.d.). A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 56 (6), pp. 1878-1880. [Online].